In addition, recent studies have shown that mice with MCP-1 receptor deficiency are given DSS to induce experimental colitis animal models, and the number of ulcers in the intestine and the degree of inflammation were reduced compared to normal mice. This evidence concerns the gene CCR2 and colitis.